| 2017-04 | Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data | 공구 |
| 2015-06 | Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma | 공구 |
| 2014-09 | Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification | 공구 |
| 2014-04 | Genomic profile analysis of diffuse-type gastric cancers | 공구 |
| 2013-01 | High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2 alpha | 공구 |
| 2013-01 | High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2 alpha | 공구 |
| 2017-04 | HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures | 공구 |
| 2011-03 | The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer | 공구 |
| 2016-06 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences | 공구 |
| 2012-09 | Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway | 공구 |
| 2011-11 | Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1 alpha mediated by the PTEN/PI3K/Akt pathway | 공구 |
| 2014-03 | Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer | 공구 |
| 2014-03 | Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer | 공구 |
| 2017-05 | LSD1 demethylates HIF1 alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis | 공구 |
| 2015-05 | MEL-18 loss mediates estrogen receptor-alpha downregulation and hormone independence | 공구 |
| 2015-06 | MEL-18, a tumor suppressor for aggressive breast cancer | 공구 |
| 2020-09 | NSD3-induced methylation of H3K36 activates NOTCH signaling to drive breast tumor initiation and metastatic progression | 공구 |
| 2015-07 | Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis | 공구 |
| 2020-02 | Pan-cancer analysis of whole genomes | 공구 |
| 2018-09 | Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer | 공구 |
| 2018-04 | Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer | 공구 |
| 2016-12 | Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression | 공구 |
| 2017-03 | A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers | 공구 |
| 2016-05 | The topography of mutational processes in breast cancer genomes | 공구 |
| 2015-10 | UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1 | 공구 |
| 2017-09 | Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency | 공구 |
